With the introduction of self-expanding stents, an increased number of complex diseases were treated, with success rates comparable to those of open surgery. [14,15] In a contemporary study ...

The original prospective multicenter trial of the Palmaz stent included 486 patients. The mean luminal late loss was 15%, plus or minus 16%. Primary patency was 92%. Self-expanding stents The ...

The peripheral vascular stent market is projected to grow from USD 4,267.70 million in 2024 to USD 8,878.00 million by 2034, at a CAGR of 7.60%. Rising cases of peripheral artery disease (PAD) are ...